Overbrook Management Corp lessened its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 26.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 219,677 shares of the biopharmaceutical company’s stock after selling 79,035 shares during the period. Royalty […]
California Public Employees Retirement System grew its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,136,899 shares of the biopharmaceutical company’s stock after buying an additional 110,768 shares during the […]
Handelsbanken Fonder AB lessened its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 891,918 shares of the biopharmaceutical company’s stock after selling 39,718 shares during the quarter. Handelsbanken Fonder AB’s holdings in Royalty Pharma were worth $25,054,000 as of its most […]
Synovus Financial Corp boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 26.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,741 shares of the biopharmaceutical company’s stock after purchasing an additional 24,721 shares during the period. Synovus Financial […]
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the four ratings firms that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have issued a report on the stock […]